|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
Salix Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... Xifaxan in the prevention of travelers diarrhea. Crofelemer In 2008, the company acquired rights ... to crofelemer from Napo Pharmaceuticals, Inc. It is investigating crofelemer as an anti-se Glenmark Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... , dyslipidemia, and metabolic disorders; and Crofelemer, a Phase III clinical trial product ... Cancer Therapy Related Diarrhea – Pipeline Insight, 2020 ... Related Diarrhea Emerging Drugs Crofelemer: Napo Pharmaceuticals Crofelemer is a drug that is a chloride channel ... Players Napo Pharmaceuticals Key Products Crofelemer Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diarrhea - Drugs in Development by Stages, Target, MoA, RoA, ... Short Bowel Syndrome (Gastrointestinal) - Drugs in Development, 2021 Short Bowel Syndrome (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Short Bowel Syndrome - Drugs In Development, 2021, provides an overview of the Short Bowel ... Short Bowel Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Short Bowel Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Short Bowel Syndrome - Drugs In Development, 2022 ... Irritable Bowel Syndrome (IBS) Therapeutics: Market Research Report This report analyzes the worldwide markets for Irritable Bowel Syndrome (IBS) Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for ... Botanical and Plant-derived Drugs: Global Markets DESCRIPTION The global market for botanical and plant-derived drugs will grow from $29.4 billion in 2017 to around $39.6 billion by 2022 with a compound annual growth rate (CAGR) of 6.1% for the period of 2017-2022. The plant-derived drugs market will grow ... Cholera Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Cholera Cholera Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Cholera Infection pipeline products. DISEASE OVERVIEW Cholera infection is spread through Clostridium tetani bacteria ... Irritable bowel syndrome - Pipeline Insight, 2021 ... modified release BMC426 DA-6886 MET409 Crofelemer NBTX-001 RQ-00310941 Ser-224 ... Cholera (Infectious Disease) - Drugs in Development, 2021 Cholera (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cholera - Drugs in Development, 2021, provides an overview of the Cholera (Infectious Disease) pipeline ... Cholera Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Cholera Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cholera - Drugs in Development by Stages, Target, MoA, RoA, ... |